[New post] Osimertinib improves survival after surgery for non-small cell lung cancer

Vidya Nagalwade posted: " In the ADAURA study, patients with EGFR-mutated, stage IB to IIIA NSCLC experienced significantly longer disease-free life with adjuvant osimertinib therapy than with placebo. A new study conducted by a Yale Cancer Center researcher finds that patient" Tech Explorist Osimertinib improves survival after surgery for non-small cell lung cancer Vidya Nagalwade Jun 6 Osimertinib improves survival and reduces recurrence in non-small cell lung cancer. Read more of this post Unsubscribe to no longer receive posts from Tech Explorist. Change your email settings at manage subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://www.techexplorist.com/osimertinib-improves-survival-after-surgery-non-small-cell-lung-cancer/61503/

Get the Jetpack app to use Reader anywhere, anytime Follow your favorite sites, save posts to read later, and get real-time notifications for likes and comments. Learn how to build your website with our video tutorials on YouTube. Automattic, Inc. - 60 29th St. #343, San Francisco, CA 94110